Blue Bell Private Wealth Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Blue Bell Private Wealth Management’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-150	Closed	-$6K	–	244
2017 Q3	$6K	Hold	150	–	–	﹤0.01%	198
2017 Q2	$6K	Hold	150	–	–	﹤0.01%	204
2017 Q1	$6K	Hold	150	–	–	﹤0.01%	204
2016 Q4	$6K	Sell	150 -400	-73%	-$16.3K	﹤0.01%	217
2016 Q3	$25K	Hold	550	–	–	0.01%	268
2016 Q2	$23K	Hold	550	–	–	0.01%	275
2016 Q1	$22K	Hold	550	–	–	0.02%	285
2015 Q4	$28K	Hold	550	–	–	0.02%	274
2015 Q3	$26K	Sell	550 -200	-27%	-$12K	0.02%	285
2015 Q2	$47K	Sell	750 -200	-21%	-$12.5K	0.03%	229
2015 Q1	$58K	Sell	950 -950	-50%	-$56.3K	0.03%	202
2014 Q4	$102K	Sell	1,900 -600	-24%	-$32.8K	0.06%	158
2014 Q3	$133K	Sell	2,500 -200	-7%	-$10.2K	0.08%	137
2014 Q2	$140K	Buy	+2,700	New	+$130K	0.08%	123

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $72.7B AUM 26.4% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

PVH

Psagot Value Holdings Tel Aviv, Israel $11M AUM 32.09% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

HCIA

Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return

Blue Bell Private Wealth Management's XPH Position: Q4 2017 in Review

Blue Bell Private Wealth Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q4 2017, closing a stake of 150 shares — an estimated $6K sold.

Blue Bell Private Wealth Management first reported a position in XPH in Q2 2014 and held it in 14 quarters. The position peaked at $140K in Q2 2014. 85 funds tracked by Wall St. Rank hold XPH as of Q4 2017.

Blue Bell Private Wealth Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q4 2017 after selling out during the quarter.
Blue Bell Private Wealth Management sold 150 State Street SPDR S&P Pharmaceuticals ETF shares in Q4 2017, an estimated $6K.
Blue Bell Private Wealth Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2014 and held it in 14 quarters.
Blue Bell Private Wealth Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $140K in Q2 2014.
85 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q4 2017.

Based on Blue Bell Private Wealth Management's 13F filing for Q4 2017, filed 31 Jan 2018.